US DTC Genetic Testing Market - Focused Insights 2023-2028

US DTC Genetic Testing Market - Focused Insights 2023-2028

REPORT OVERVIEW

This report analyzes the complete US DTC Genetic testing market in-depth. Exhaustive information regarding the adoption of US DTC Genetic testing in the market.

The usage of genetic testing in the US is increasing due to the increasing curiosity regarding ancestry testing. This test provides more information regarding the people's origin in terms of geography. The number of genetic disorders impacting people is increasing in the US. This is increasing the number of people undergoing DTC testing due to the increased awareness regarding the testing and preventive measures. DTC testing provides better information regarding nutrition, medicine, personalized therapies, and more.

MARKET DEFINITION

DTC (Direct to consumer) genetic testing is a method through which patients can directly order sample collection kits and send these samples to the company through courier and get the results online within a couple of weeks. This process of testing samples for their own interest without any involvement from a physician is called DTC genetic testing.

KEY HIGHLIGHTS:

• In the US, genetic tests are usually done for multipurpose, as they are not mutually exclusive. The number of genetic tests is increasing over time
• Around 90% of genetic tests carried out are for clinical purposes. Only a limited number of genetic tests are performed for research purposes. The increasing disease population will increase the demand for DTC testing in the market as a part of preventive care.
• The increasing demand for personalized nutrition and medicine is increasing the demand for DTC in the market, especially among celebrities and bodybuilders.
• At-home DNA ancestry testing provides complete information about one’s family lineage by analysing their genetic code and by comparing it with millions of other people’s DNA. The test is usually done with a saliva sample. The current generation of the US is more curious to know about their family history.
• 23andMe is the only US FDA that has approved DTC tests for cancer patients. The DTC test has increased the number of people undergoing cancer tests. Some of the companies are providing consultations regarding genetic testing through telehealth platforms.
• People prefer for subscription model of genetic testing in the market. The longer the subscription more detailed results for the sequences are provided. This provides more personalized solutions to the patients

VENDORS LIST

Key Vendors

• Ancestry
• 23andME

Other Prominent Vendors

• 24GENETICS
• Molecular vision
• Dante Genomics
• Living DNA
• Family Tree DNA
• FullGenomes
• Genebase
• MyHeritage
• NebulaGenomics
• Veritas
• Homedna
• ColorHealth
• Nucleus

REPORT HIGHLIGHTS

SEGMENTATION & FORECAST

• Test Type
• Ancestry & Relationship
• Predictive Testing
• Nutrigenomics
• Carrier Testing
• Others
• Technology
• Single Nucleotide polymorphism
• Whole Genome Sequencing
• Targeted Analysis
• Distribution Channel
• Online
• Offline

MARKET STRUCTURE

• Market Dynamics
• Competitive Landscape
• Key Vendors
• Other Prominent Vendors
• Strategic Recommendations
• Quantitative Summary
• Abbreviations

APPENDIX

• Research Methodology
• Abbreviations
• About Arizton